JPMorgan Chase & Co’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361 | Sell |
921
-27
| -3% | -$11 | ﹤0.01% | 5841 |
|
|
2025
Q1 | $294 | Buy |
948
+27
| +3% | +$8 | ﹤0.01% | 5878 |
|
|
2024
Q4 | $386 | Hold |
921
| – | – | ﹤0.01% | 5776 |
|
|
2024
Q3 | $904 | Hold |
921
| – | – | ﹤0.01% | 5666 |
|
|
2024
Q2 | $1.4K | Sell |
921
-10,760
| -92% | -$16.4K | ﹤0.01% | 5551 |
|
|
2024
Q1 | $26.5K | Sell |
11,681
-5,893
| -34% | -$13.4K | ﹤0.01% | 5164 |
|
|
2023
Q4 | $51.5K | Hold |
17,574
| – | – | ﹤0.01% | 5002 |
|
|
2023
Q3 | $74.3K | Sell |
17,574
-3,390
| -16% | -$14.3K | ﹤0.01% | 4767 |
|
|
2023
Q2 | $184K | Buy |
20,964
+20,673
| +7,104% | +$181K | ﹤0.01% | 4319 |
|
|
2023
Q1 | $1K | Hold |
291
| – | – | ﹤0.01% | 5629 |
|
|
2022
Q4 | $4K | Sell |
291
-399
| -58% | -$5.49K | ﹤0.01% | 5247 |
|
|
2022
Q3 | $6K | Buy |
690
+234
| +51% | +$2.04K | ﹤0.01% | 5150 |
|
|
2022
Q2 | $7K | Sell |
456
-5,453
| -92% | -$83.7K | ﹤0.01% | 5237 |
|
|
2022
Q1 | $71K | Buy |
5,909
+1,228
| +26% | +$14.8K | ﹤0.01% | 4877 |
|
|
2021
Q4 | $77K | Buy |
4,681
+879
| +23% | +$14.5K | ﹤0.01% | 4916 |
|
|
2021
Q3 | $60K | Buy |
3,802
+520
| +16% | +$8.21K | ﹤0.01% | 4896 |
|
|
2021
Q2 | $303K | Buy |
+3,282
| New | +$303K | ﹤0.01% | 4279 |
|
|
2015
Q2 | – | Sell |
-14,895
| Closed | -$2.66M | – | 3410 |
|
|
2015
Q1 | $2.66M | Sell |
14,895
-3,334
| -18% | -$595K | ﹤0.01% | 2416 |
|
|
2014
Q4 | $4.33M | Sell |
18,229
-1,456
| -7% | -$346K | ﹤0.01% | 2123 |
|
|
2014
Q3 | $4.39M | Buy |
19,685
+7,012
| +55% | +$1.56M | ﹤0.01% | 2081 |
|
|
2014
Q2 | $3.34M | Sell |
12,673
-3,071
| -20% | -$809K | ﹤0.01% | 2216 |
|
|
2014
Q1 | $5.11M | Buy |
+15,744
| New | +$5.11M | ﹤0.01% | 2038 |
|